Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma
SpainStudy on the Safety and Effectiveness of IMM-101 with Radiotherapy for Patients with Limited Metastatic Pancreatic Cancer
The NetherlandsStudy of LY3295668 Erbumine for Patients with Relapsed or Refractory Neuroblastoma
SpainStudy on Liver Cancer in Cirrhosis Patients Using Idarubicin and Lipiodol Injection
FranceStudy for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination
ItalyStudy of venetoclax and azacitidine combination treatment for acute myeloid leukemia patients with measurable residual disease after chemotherapy or before stem cell transplant
SpainStudy of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
BulgariaStudy of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer
BelgiumStudy on Continuing Elotuzumab Treatment for Patients with Multiple Myeloma from Previous Trials
RomaniaStudy on Adjuvant Treatment for Unilateral Retinoblastoma with Vincristine Sulfate and Drug Combination in Patients After Primary Eye Removal
FranceStudy on Durvalumab for Patients with Poor General Condition and Advanced Non-Small Cell Lung Cancer
FranceThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
